Additionally, we compared the transcriptome profile of FFD-fed Ldlr-/-.Leiden mice with a human gene set that differentiates human NASH patients with severe fibrosis from those with mild fibrosis. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.